A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

NCT00645229 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Please see Detailed Description for termination reason.

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: Ziprasidone

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.